Sana Biotechnology, Inc. (NASDAQ: SANA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SANA BIOTECHNOLOGY, INC.

Sana Biotechnology, Inc. (NASDAQ: SANA)
Listen to this Section


$2.99
-0.1350 ( -4.33% ) 2.5M

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.

Market Data


Open $2.99
Previous Close $3.12
Volume 2.5M
Market Cap $868.27M
Day Range $2.98 - $3.24
52 Week Range $2.26 - $6.55
Shares Outstanding 278.29M
Change % -4.33%
Net Change ▼ -0.1350
Insider Ownership -0.02%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2021
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -65,199.00

Date Type Amount Purchased Purchaser
2024-04-08 Sale -2774.00 Bishop Hans Edgar
2024-03-11 Sale -25000.00 Yang Patrick Y
2024-03-08 Sale -67083.00 Hardy Nathan
2024-03-08 Sale -67083.00 WILLIAMS DOUGLAS E
2024-03-08 Sale -200000.00 Harr Steve
2024-03-08 Sale -37500.00 Hordo Christian
2024-03-08 Sale -44167.00 Cassidy Bernard J
2024-02-14 Buy 2727272.00 Flagship Pioneering Inc.
2024-02-12 Buy 363637.00 ARCH Venture Fund X, L.P.
2024-02-12 Buy 363637.00 CRANDELL KEITH

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 79 Nov 06, 2025
8-k 8K-related 11 Nov 06, 2025
4 Insider transactions 1 Oct 07, 2025
8-k 8K-related 10 Sep 05, 2025
8-k 8K-related 10 Aug 29, 2025
8-k 8K-related 11 Aug 11, 2025
10-q Quarterly Reports 80 Aug 11, 2025
8-k 8K-related 19 Aug 07, 2025
8-k 8K-related 12 Aug 06, 2025
4 Insider transactions 1 Jul 08, 2025

Latest News


× Before browsing our site, please accept our cookies policy